Cobrado L, Silva-Dias A, Azevedo M M, Rodrigues A
Division of Microbiology, Department of Pathology, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200 Porto, Portugal.
CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.
Antimicrob Resist Infect Control. 2017 Nov 3;6:110. doi: 10.1186/s13756-017-0269-x. eCollection 2017.
Whenever the rate of central line-associated bloodstream infections (CLABSIs) remains high even after the implementation of preventive strategies, the use of chlorhexidine/silver sulfadiazine (CSS) or minocycline/rifampin (MR)-impregnated central venous catheters (CVCs) is currently recommended. Nevertheless, the efficacy of such CVCs against and other emerging non- spp. has been insufficiently studied. This study aims to compare the activity of CSS and MR-impregnated CVCs against the yeasts most frequently isolated from CLABSIs.
For biofilm formation assays, type strains and clinical isolates of , and sensu stricto were used. Segments of standard polyurethane, MR and second-generation CSS-CVCs were tested. The biofilm metabolic activity was measured by a semi-quantitative XTT reduction assay.
CSS catheter segments significantly reduced the biofilm metabolic activity by all tested spp., with inhibition ranging from 60% to 100%. The MR catheter segments promoted and biofilm formation and exhibited an inconspicuous effect against .
Among the recommended antimicrobial CVCs, CSS-CVCs proved to be superior in the inhibition of biofilm formation by the most frequent yeasts causing CLABSIs. Data from this in vitro study may suggest that patients at high risk for invasive candidosis could benefit from the use of CSS-CVCs.
即使在实施预防策略后,中心静脉导管相关血流感染(CLABSI)的发生率仍居高不下时,目前建议使用洗必泰/磺胺嘧啶银(CSS)或米诺环素/利福平(MR)浸渍的中心静脉导管(CVC)。然而,此类CVC对白色念珠菌及其他新出现的非白色念珠菌属的疗效尚未得到充分研究。本研究旨在比较CSS和MR浸渍的CVC对CLABSI中最常分离出的酵母菌的活性。
对于生物膜形成试验,使用白色念珠菌、光滑念珠菌和热带念珠菌的标准菌株及临床分离株。对标准聚氨酯、MR和第二代CSS - CVC的片段进行测试。通过半定量XTT还原试验测量生物膜代谢活性。
CSS导管片段显著降低了所有测试念珠菌属的生物膜代谢活性,抑制率在60%至100%之间。MR导管片段促进了光滑念珠菌和热带念珠菌的生物膜形成,对白色念珠菌的作用不明显。
在推荐的抗菌CVC中,CSS - CVC在抑制导致CLABSI的最常见酵母菌的生物膜形成方面被证明更具优势。这项体外研究的数据可能表明,侵袭性念珠菌病高危患者可能受益于使用CSS - CVC。